CEVA awarded Good Distribution Practice (GDP) Award

IEA Life Sciences Ireland division recognizes CEVA for delivering highest standards to the pharmaceutical and medical devices industry.

Dublin, 16 June 2010 CEVA Logistics, one of the worlds leading supply chain companies, has been presented with Full Passport Status for Good Distribution Practice (GDP) for providing best-in-class supply chain services to the pharmaceutical, medical device and diagnostics manufacturing sectors by the IEA (Irish Exporters Association) Life Sciences Ireland division.

John Whelan, CEO of the IEA stated: "Ireland is a global centre of excellence in the Life Sciences industry with 18 of the top 20 global brands being produced here. To retain this pre-eminent position in this very competitive and regulated industry we need exceptional logistics supply partners. We are delighted that CEVA has put in the investment to reach the GDP Passport standard and ensure the high level of supply chain support will continue to be made available to the pharmaceutical and medical devices industry to reach their global markets efficiently out of Ireland."

Leigh Pomlett, CEVAs Executive Vice President in UK & Ireland said:  CEVA is committed to operational excellence and our company culture is well aligned to the Life Sciences ethos which focuses on driving export excellence.  We are delighted that the IEA Life Sciences has recognized our professionalism in the healthcare sector by presenting CEVA in Ireland with the GDP award.
 
In order to receive the GDP award, CEVA had to demonstrate its expertise and capabilities within the sector.  The process involved an inspection by the IEA of CEVAs premises, transport and vehicles, procedures, records and training which were all assessed against stringent criteria.

Gary OConnor, CEVAs Country Manager in Ireland, attended the presentation and accepted the award on behalf of CEVA and said: CEVA is delighted to receive this prestigious award from the IEA Life Sciences division. CEVA recognizes that cost effective, innovative and compliant solutions are critical to companies operating in the life sciences sector and that the practices that form the basis of the GDP Passport will help to ensure that the logistics sector is well equipped to support Life Sciences in Ireland into the future.

The GDP Passport Code was drawn up by the Life Sciences industry and the IEA in consultation with the Irish Medical Board (IMB) to meet the requirements as set out in the IMBs Guidelines and the requirements of EU Guidelines. The GDP Passport Code aims to bring Ireland to the highest standard required by the highly regulated pharmaceutical and medical devices global industry.